Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

July 31, 2013

Conditions
Melanoma
Interventions
DRUG

AZD6244

Oral liquid or Capsule

DRUG

Temozolomide

oral

Trial Locations (33)

Unknown

Research Site, Santa Monica

Research Site, Aurora

Research Site, Miami Beach

Research Site, Niles

Research Site, Boston

Research Site, Buffalo

Research Site, New York

Research Site, Oklahoma City

Research Site, Pittsburgh

Research Site, Nashville

Research Site, Ciudad de Buenos Aires

Research Site, Vicente López

Research Site, Heidelberg

Research Site, Nedlands

Research Site, Waratah

Research Site, Sankt Pölten

Research Site, Vienna

Research Site, Belo Horizonte

Research Site, Curitiba

Research Site, Goiânia

Research Site, Porto Alegre

Research Site, Salvador

Research Site, São Paulo

Research Site, Oshawa

Research Site, Montreal

Research Site, Odense

Research Site, Boulogne-Billancourt

Research Site, Nantes

Research Site, Villejuif

Research Site, Zurich

Research Site, Glasgow

Research Site, London

Research Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY